AI Search: TEM Slips Modestly as Profit-Taking Follows Recursion Rally
## What happened
Tempus AI (TEM) is trading modestly lower today, with the decline characterized as profit-taking and technical selling rather than a response to any fresh negative development. The move comes even as the broader market climbs, making TEM's pullback stand out against a rising tape. The stock had previously rallied violently on the expanded Recursion partnership, and today's reversal follows that sharp run-up. The development was reported by Timothy Sykes at timothysykes.com.
## Why it matters for TEM
The context here is the recent violent rally tied to the expanded Recursion partnership. With no new negative news driving the reversal, today's modest decline appears to reflect investors locking in gains after that aggressive move higher, along with technical selling pressure. For shareholders, the key takeaway is that the pullback looks like a natural digestion of the recent surge rather than a deterioration in the company's story.
## How the market reacted
TEM's price moved down modestly today. The move came despite a climbing broader market, underscoring that the selling was stock-specific. Ezbrisk's read is that the market reaction is a fair one relative to the news — in this case, the absence of fresh negative news and the presence of profit-taking after a violent rally suggest the modest decline is a reasonable response rather than an overreaction.
## What this news leaves open
Several questions remain. Will the profit-taking persist, or will buyers step back in following the rally on the expanded Recursion partnership? How much of the recent gains investors choose to hold onto could shape the stock's near-term path. It also remains to be seen whether TEM can decouple from the technical selling pressure and resume moving with the broader market, which is currently climbing. And with no fresh negative news behind the reversal, investors may watch for whether any new developments emerge that could change the picture.
Previous verdicts for TEM
- TEM slides sharply — 2026-10-06
- AI Search: Tempus AI Spikes Sharply on ECG Valvular Screening Coverage — 2026-10-05
- FDA clearance lifts TEM — 2026-09-28
- Earnings beat lifts TEM — 2026-09-25
- TEM Surges Violently — 2026-09-24
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works